IASIS PHARMA participated in the 18th Panhellenic Conference of Dermatology & Venereology which took place on November 03-06, 2022 at the “Intercontinental” Hotel in Athens.
At IASIS PHARMA exhibition stand, the new & unique Isotroin 30mg was presented for the first time. Isotroin 30mg completes the range of the other Isotroin contents (10mg, 20mg & the also unique 40mg).
Isotroin®/Isotretinoin is indicated for the severe forms of Acne that are resistant to treatment with systemic antibiotics and topical therapy.
The following products were also presented:
Modiwart®/Imiquimod, an innovative modifier of the immune response system indicated for the treatment of: External Genital Warts, Superficial Basal Cell Carcinoma and Actinic keratosis.
Combi®, a combination of fluprednidene+miconazole cream for the treatment of Inflammatory Dermatomycoses such as Fungal Vaginitis (or Vaginal Candidiasis).